R

Rovia Clinical Research

Multispecialty clinical trial site network

Overview

Rovia Clinical Research runs a network of multi-specialty clinical research sites across the United States to conduct clinical trials for drugs, devices, and diagnostics. It uses a hybrid site model that combines fully-owned, stand-alone centers with embedded specialists in independent medical practices to provide on-site trial support. This setup covers study start-up, patient enrollment, data collection and analysis, logistics, training, and business development, helping sponsors run trials more efficiently. Rovia differentiates itself through its scale, diverse patient access, and integrated services that reduce the burden on investigators, accelerated site activation, and a growing investigator network backed by acquisitions and private equity. The company’s goal is to deliver predictable, high-quality trial execution across multiple therapeutic areas by expanding its network and capabilities, serving major pharmaceutical and biotech clients with timely, well-run studies.

Significant Headcount Growth

Work here?Claim your company

About Rovia Clinical Research

Simplify's Rating
Why Rovia Clinical Research is rated
C+
Rated B on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsConsultingHealthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Jacksonville, FL

Founded

2007

Get referred to Rovia Clinical Research

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • September 15, 2026 acquisitions expanded Rovia into Alabama and strengthened Phase I coverage.
  • Gauge Capital keeps funding rollups; September 2025 and 2026 deals show acquisition momentum.
  • Underserved-community positioning helps sponsors recruit diverse patients for obesity, infectious disease, and diagnostics studies.

What critics are saying

  • Rovia depends on Gauge Capital and debt financing, pressuring returns if growth slows.
  • Integration across 20 sites risks uneven quality and delayed startup, especially after 2025-2026 acquisitions.
  • Large site networks like Velocity, Javara, and Headlands can outbid Rovia for sponsor relationships.

What makes Rovia Clinical Research unique

  • Rovia's 2026 network spans 20 locations across 8 states with 80 investigators.
  • Its hub-and-spoke model embeds specialists inside practices, speeding site activation and enrollment.
  • Acquisitions added obesity, hepatology, cardiometabolic, diagnostics, and Phase I capabilities in 2025-2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Performance Bonus

Growth & Insights and Company News

6 month growth

4%

1 year growth

20%

2 year growth

33%
Gauge Capital
Sep 29th, 2025
Rovia Clinical Research Announces Acquisitions of StudyMetrix Research and Coastal Research Institute

Gauge Capital, Rovia Clinical Research Announces Acquisitions of StudyMetrix Research and Coastal Research Institute, September 29 2025

Recently Posted Jobs

Sign up to get curated job recommendations

Rovia Clinical Research is Hiring for 8 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs